3月20日,Inhibrx Biosciences, Inc.(INBX.US)公布财报,公告显示公司2024财年净利润为16.88亿美元,同比增加803.33%;其中营业收入为200000.00美元,同比减少88.89%,每股基本收益为116.58美元。从资产负债表来看,Inhibrx Biosciences, Inc.(INBX.US)总负债47.18百万美元,其中短期债务1.60百万美元,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.